Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Danaher Corporation (DHR) vs Vistra Corp (VST) Price & Performance

Danaher CorporationTrade
Vistra CorpTrade

Price performance (Past 24H)

Key statistics

Danaher Corporation vs Vistra Corp — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while Vistra Corp trades at $161.48 (market cap $52.41B). The key difference: Danaher Corporation is far larger — about 2.9× Vistra Corp's market cap, and Danaher Corporation pays the higher dividend (0.74%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Vistra Corp for 32 Days on average.

DHRVST
Market Cap
$152.87B$52.41B
Volume
5,228,69811,278,074
Sector
HealthUtilities
52-Week High
$242.05$210.85
52-Week Low
$161.91$134.71
Typical Hold Time
69 Days32 Days
Enterprise Value
$175.08B$74.34B
Dividend Yield
0.74%0.59%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Danaher Corporation

Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.

The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.

Vistra Corp

Vistra Corp. (VST) trades at $156.14, down 6.35% over 24 hours amid mixed earnings history, with a Q1 2026 beat but Q4 2025 and Q2 2026 misses. Technical indicators show a bullish trend with support at $152 and resistance at $164, while fundamentals highlight strong profitability with an 11.55% net income margin and 75.73% ROE. Recent developments include a $4.2 billion US loan for nuclear power expansion and a 20-year power deal with New Era Energy, positioning VST to capitalize on AI-driven electricity demand.

Outlook remains positive with a consensus price target of $215.23 (38% upside), supported by analyst bullishness (91.3% buy ratings) and institutional interest. Key risks include execution on nuclear projects, debt levels, and volatile earnings. The stock offers exposure to the AI power scarcity theme, but investors should monitor Q3 2026 results on November 6 for confirmation of growth trends.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DHR
3% Buy97% Sell
Avg holding period · 69 Days
VST
49% Buy51% Sell
Avg holding period · 32 Days

Top news

Latest headlines on both assets

About Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.

Read more on DHR →

About Vistra Corp

Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.

Read more on VST →